Skip to content

PZLV · ARCA · ETF

Pzena U.S. Large Cap Value ETF (PZLV) Price, Holdings & Fees

$419.92−0.02%−$0.08End-of-day price as of Oct 9, 2026

Pzena U.S. Large Cap Value ETF (PZLV) closed at $419.92 on Oct 9, 2026, down 0.02% from the previous close of $420.00.

Share price, past year

1Y +24.66%

52-week range $336.84 – $436.43. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$419.92
Sep 30, 2026$418.16
Aug 31, 2026$422.66
Jul 31, 2026$403.48
Jun 30, 2026$370.98
May 29, 2026$363.65
Apr 30, 2026$352.23
Mar 31, 2026$344.79
Feb 27, 2026$361.13
Jan 30, 2026$365.50
Dec 31, 2025$361.41
Nov 28, 2025$371.75
Oct 31, 2025$350.34

Key statistics

Expense ratio
0.60%
as of Mar 31, 2026
Net assets
$62M
as of May 31, 2026
Holdings
41
as of May 31, 2026
52-week range
$336.84 – $436.43

Pzena U.S. Large Cap Value ETF's expense ratio is 0.60%: $60.00 a year on $10,000 invested.

Holdings

Pzena U.S. Large Cap Value ETF held 41 investments worth $62.01M as of May 31, 2026. Its largest holding was Humana Inc, at 5.87% of the fund.

Pzena U.S. Large Cap Value ETF largest holdings by share of net assets
#Holding% of fundValue
1Humana IncHUM5.87%$3.64M
2Baxter International IncBAX4.44%$2.75M
3Skyworks Solutions IncSWKS3.97%$2.46M
4CVS Health CorpCVS3.78%$2.35M
5Lear CorpLEA3.68%$2.28M
6Magna International IncMGA3.65%$2.27M
7Dollar General CorpDG3.61%$2.24M
8Capital One Financial CorpCOF3.17%$1.97M
9MetLife IncMET3.10%$1.92M
10Cognizant Technology SolutionsCTSH3.10%$1.92M
11Wells Fargo & CoWFC3.08%$1.91M
12Robert Half IncRHI2.95%$1.83M
13CDW Corp/DECDW2.92%$1.81M
14Bristol-Myers Squibb CoBMY2.75%$1.70M
15Globe Life IncGL2.68%$1.66M
16Corebridge Financial IncCRBG2.61%$1.62M
17PPG Industries IncPPG2.60%$1.61M
18LKQ CorpLKQ2.51%$1.55M
19Knight-Swift Transportation HoKNX2.49%$1.54M
20Global Payments IncGPN2.49%$1.54M
21Fresenius Medical Care AGFMS2.48%$1.54M
22Citigroup IncC2.36%$1.46M
23Tyson Foods IncTSN2.24%$1.39M
24Universal Health Services IncUHS2.09%$1.29M
25PVH CorpPVH2.05%$1.27M

Top 25 of 41 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Pzena U.S. Large Cap Value ETF holdings by asset type
Asset type% of fund
Stocks98.24%
Pzena U.S. Large Cap Value ETF holdings by country, largest 5
Country% of fund
United States89.45%
Canada3.65%
Germany2.48%
Ireland1.39%
United Kingdom1.27%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Pzena U.S. Large Cap Value ETF's total return was +10.94%, as reported to the SEC.

Pzena U.S. Large Cap Value ETF monthly total returns
MonthTotal return
May 31, 2026+2.61%
Apr 30, 2026+8.12%
Mar 31, 20260.00%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Pzena U.S. Large Cap Value ETF
Ticker
PZLV
Exchange
ARCA
Fund type
ETF
Trust
ADVISORS SERIES TRUST
SEC series ID
S000102224
SEC CIK
0001027596
Fractional shares
No

Recent SEC filings

Shareholder reports and prospectuses are filed by ADVISORS SERIES TRUST, the trust behind Pzena U.S. Large Cap Value ETF, and cover all of its funds.

Frequently asked questions

What is PZLV's price?

Pzena U.S. Large Cap Value ETF (PZLV) closed at $419.92 on Oct 9, 2026, down 0.02% from the previous close of $420.00.

What is PZLV's expense ratio?

Pzena U.S. Large Cap Value ETF's expense ratio is 0.60%: $60.00 a year on $10,000 invested.

What does PZLV hold?

Pzena U.S. Large Cap Value ETF held 41 investments worth $62.01M as of May 31, 2026. Its largest holding was Humana Inc, at 5.87% of the fund. Its five largest holdings were Humana Inc, Baxter International Inc, Skyworks Solutions Inc, CVS Health Corp, Lear Corp.

How has PZLV performed?

Over the 3 months to May 31, 2026, Pzena U.S. Large Cap Value ETF's total return was +10.94%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 30, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Mar 31, 2026. Prices are generated sample data for development. Data sources and disclosures